Viewing Study NCT06634927


Ignite Creation Date: 2025-12-25 @ 5:11 AM
Ignite Modification Date: 2026-01-09 @ 7:20 PM
Study NCT ID: NCT06634927
Status: COMPLETED
Last Update Posted: 2025-08-01
First Post: 2024-09-24
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Pharmacokinetic Similarity, Safety, and Immunogenicity of Semaglutide Injection and Ozempic ® Injection in Healthy Subjects.
Sponsor: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module